Clinical Trial Supply And Logistics Market Size, Share, and Trends 2024 to 2034

The global clinical trial supply and logistics market size was valued at USD 3.70 billion in 2023 and it is expected to hit around USD 7.85 billion by 2033, poised to grow at a CAGR of 7.79% during the forecast period 2024 to 2033.

Clinical Trial Supply and Logistics Market Key Takeaways

• North America contributed more than 36.15% of market share in 2023.
• By Service, the logistics & distribution segment is expected to dominate the market with revenue share of 27.68% in 2023.
• By Phase, the phase III segment is expected to hold the largest revenue share of 40.38% in 2023.
• By End-user, the pharmaceuticals segment generated more than 42.11% of revenue share in 2023.
• By Therapeutic Area, the cardiovascular diseases segment has accounted largest market share 32.34% in 2023.

U.S. Clinical Trial Supply and Logistics Market Size from 2024 to 2033

The U.S. clinical trial supply and logistics market size was valued at USD 1.11 billion in 2023 and is projected to surpass around USD 2.30 billion by 2033, expanding at a CAGR of 7.58% between 2024 and 2033.

North America is expected to dominate the market over the forecast period due to the pharmaceutical hub. North America, particularly the United States, is a global hub for pharmaceutical and biotechnology research and development. The region is home to numerous pharmaceutical companies, contract research organizations (CROs), and academic institutions conducting clinical trials. These entities rely on clinical trial supply & logistics providers to support their trials. Moreover, the stringent regulatory environment is another important factor that propels the market growth in the area.

North America, particularly the United States, is a global hub for pharmaceutical and biotechnology research and development. The region is home to numerous pharmaceutical companies, contract research organizations (CROs), and academic institutions conducting clinical trials. These entities rely on clinical trial supply & logistics providers to support their trials. Moreover, the stringent regulatory environment is another important factor that propels the market growth in the area.

The United States Food and Drug Administration (FDA) and Health Canada are stringent regulatory authorities overseeing clinical trials and drug approvals in the region. Compliance with their regulations is essential. Clinical trial supply & logistics providers in the area have expertise in navigating these regulatory frameworks and ensuring that trial materials meet compliance requirements. Thus, this is expected to drive the market growth in the region.

The United States Food and Drug Administration (FDA) and Health Canada are stringent regulatory authorities overseeing clinical trials and drug approvals in the region. Compliance with their regulations is essential. Clinical trial supply & logistics providers in the area have expertise in navigating these regulatory frameworks and ensuring that trial materials meet compliance requirements. Thus, this is expected to drive the market growth in the region.

Asia Pacific is expected to grow at the highest CAGR over the forecast period. The region has witnessed a surge in clinical trial activity, driven by factors such as large patient populations, diverse disease demographics, and cost advantages. Pharmaceutical companies and CROs are conducting an increasing number of trials in the region, leading to greater demand for clinical trial supply & logistics services. Thus, the aforementioned stats are expected to drive the market growth during the forecast period.

The region has witnessed a surge in clinical trial activity, driven by factors such as large patient populations, diverse disease demographics, and cost advantages. Pharmaceutical companies and CROs are conducting an increasing number of trials in the region, leading to greater demand for clinical trial supply & logistics services. Thus, the aforementioned stats are expected to drive the market growth during the forecast period.

• The North America clinical trial supply and logistics market size was valued at USD 1.33 billion in 2023 and it is expected to hit around USD 2.75 billion by 2033, poised to grow at a CAGR of 7.48% during the forecast period 2024 to 2033.
• The Europe clinical trial supply and logistics market size was estimated at USD 1.07 billion in 2023 and it is expected to hit around USD 2.30 billion by 2033 with a CAGR of 7.95% from 2024 to 2033.
• The Asia Pacific clinical trial supply and logistics market size was accounted for USD 8.49 billion in 2023 and is predicted to reach around USD 1.95 billion by 2033, growing at a CAGR of 8.66% from 2024 to 2033.
• The MEA clinical trial supply and logistics market size was exhibited at USD 162.90 million in 2023 and it is expected to be worth around USD 302.14 million by 2033, poised to grow at a CAGR of 6.37% from 2024 to 2033.

Clinical Trial Supply and Logistics Market Overview:

Clinical trial supply & logistics refers to the planning, management, and execution of the procurement, storage, distribution, and tracking of pharmaceutical products, medical devices, and other materials needed for clinical trials. Clinical trials are essential for evaluating the safety and efficacy of new drugs, therapies, and medical interventions before they can be approved for widespread use. Managing the supply chain and logistics for clinical trials is a critical aspect of ensuring that these trials are conducted efficiently and effectively.

Clinical Trial Supply and Logistics Market Growth Factors

The global clinical trial supply and logistics market involves sourcing and acquiring the necessary investigational products, placebos, comparators, and other materials required for the clinical trial. These materials are often provided by pharmaceutical companies or contract research organizations.

The clinical trial supply & logistics market is being driven by several factors including a growing number of clinical trials, stringent regulatory requirements, advancements in technology, a rise in rare disease research and growing mergers and acquisitions.

Report Scope of the Clinical Trial Supply and Logistics Market:

Market Dynamics:

Driver

Growing research on rare disease

The growing research on rare diseases is expected to drive the growth of the clinical trial supply & logistics market over the forecast period. Clinical trials focused on rare diseases on the rise, and many of these conditions have specific supply chain challenges due to limited patient populations and specialized treatments.

• For instance, rare diseases are frequently chronic, severely disabling, and sometimes even fatal. A rare illness affects fewer than one in 2,000 persons, according to the Canadian Organization for Rare Disorders, the same standard used by the European Union. A rare disease affects fewer than 200,000 persons in the United States, according to the National Institutes of Health and Human Services.

As scientists and researchers start emphasizing on the research activities that are associated with such diseases, the market is expected to accelerate while addressing the challenges of the supply chain. Thus, this is expected to drive the market growth during the forecast period.

Restraint

Regulatory compliance burden

The pharmaceutical and clinical trial industry operates within a highly regulated environment. Meeting regulatory approvals while considering stringent guidelines from agencies like the FDA and EMA can be complicated, time-consuming and costly. This includes adhering to good clinical practice and good distribution practice guidelines, which demand proper documentation and quality controls. Thus, this is expected to hamper the clinical trial supply & logistics market during the projected period.

Opportunity

Increasing collaborations

The increasing collaboration among the key market players is expected to offer a lucrative opportunity for market growth during the forecast period. For instance, in April 2022, Thermo Fisher Scientific Inc and Matrix clinical trials, a service of Matrix medical network, announced that they are working together to develop an innovative decentralized clinical trial (DCT) solution to deliver clinical trials to patients. To help in detecting, retaining, and attracting trial participants while guaranteeing a favorable patient experience, the company is deploying cutting-edge Matrix mobile research sites around the United States. The two businesses are simultaneously looking for ways to extend their partnership to new regions.

Service Insights

Based on the service, the global clinical trial supply & logistics market is segmented into logistics & distribution, storage & retention, packaging, labeling, blinding, manufacturing, comparator sourcing and others. The logistics & distribution segment is expected to dominate the market over the forecast period. The logistics and distribution aspect of the clinical trial supply & logistics market is a critical component that ensures investigational products and materials are efficiently transported to the right locations at the right time while maintaining compliance with regulatory requirements.

Clinical trials are often conducted on a global scale, involving multiple countries and regions. Efficient global distribution is essential to ensure that investigational products reach various clinical trial sites, often in different time zones, climates, and regulatory environments. Thus, this is expected to drive the segment expansion during the forecast period.

Clinical Trial Supply And Logistics Market, By Service, 2020-2023 (USD Million)

Phase Insights

Based on the phase, the global clinical trial supply & logistics market is segmented into Phase I, Phase II, Phase III and Phase IV. The Phase III segment is expected to hold the largest revenue share over the forecast period. Phase III trials typically involve a larger number of participants, often spanning multiple sites and countries. The scale and complexity of phase III trials require extensive planning and logistics support to ensure the timely delivery of investigational products to all trial sites.

Moreover, patient recruitment and retention are critical during phase III trials. Efficient logistics ensure that patients have access to the investigational product at their respective trial sites, reducing delays and dropouts due to supply issues. Furthermore, these trials are conducted on a global scale to ensure diverse patient populations. The clinical trial supply & logistics market helps manage the global distribution of investigational products, considering international regulations, customs, and temperature control requirements. Thereby, driving the segment growth over the forecast period.

Clinical Trial Supply And Logistics Market, By Phase, 2020-2023 (USD Million)

End User Insights

Based on the end user, the global clinical trial supply & logistics market is segmented into pharmaceuticals, biologicals, and medical devices. The pharmaceuticals segment is expected to hold the largest market share over the forecast period. The pharmaceutical industry relies on clinical trials to demonstrate the safety and efficacy of new drugs and therapies. Clinical trial supply & logistics providers assist pharmaceutical companies in procuring, packaging, labeling, and distributing investigational products to trial sites. They ensure that these materials are delivered on time and in the required condition to facilitate the smooth execution of clinical trials.

Moreover, the pharmaceutical industry has seen a significant increase in the development of biologic drugs, including monoclonal antibodies, gene therapies, and cell therapies. These products often have unique handling and storage requirements, such as cold chain logistics. Clinical trial supply & logistics providers offer specialized solutions to ensure the integrity and safety of biological materials during transportation and storage. Thus, this is expected to propel the market growth during the forecast period.

Clinical Trial Supply And Logistics Market, By End User, 2020-2023 (USD Million)

Therapeutic Area Insights

Based on the therapeutic area, the global clinical trial supply & logistics market is segmented into oncology, cardiovascular diseases, respiratory diseases, CNS and mental disorders and others. The cardiovascular diseases segment is expected to hold the largest market share over the forecast period. The segment growth is attributed to the growing prevalence of cardiovascular disease across the globe. Thus, the aforementioned statistics are expected to drive the segment expansion over the forecast period.

Clinical Trial Supply And Logistics Market, By Therapeutic Area, 2020-2023 (USD Million)

Recent Development

• In March 2023, a leading supplier of unified clinical trial management solutions Cloudbyz introduced Cloudbyz EDC 2.0, a new Electronic Data Capture (EDC) platform. By providing a smooth, secure, and effective cloud platform for gathering, maintaining, and analyzing clinical trial data, Cloudbyz EDC 2.0, which is intended to transform the clinical research environment, enables researchers to provide game-changing therapies more quickly and intelligently. A user-friendly user interface, cutting-edge data security, intelligent data validation, real-time data monitoring, analytics, and compliance with international regulatory requirements are all features of the Cloudbyz EDC platform. Organizations may maximize their research efforts using Cloudbyz EDC, cut down on human mistakes, and speed up regulatory clearances.
• In February 2023, a fast-growing French firm called COLCA-MS, located close to Lyon and specializing in pharmaceutical logistics was acquired by Petrone Group for a majority interest in developing supply chain solutions that are tailored to the unique properties of each product. Over time, COLCA MS has created a specialized field of knowledge for pharmaceutical companies working with rare and orphan diseases. The purchase affirms the Petrone Group's aim to maintain its trajectory for international expansion and to make use of French management's expertise and network to strengthen its Euromed-Pharma companies.
• In August 2022, Bomi Group, a preeminent international leader in healthcare logistics, announced plans to be acquired by UPS. In addition to over 3,000 highly experienced Bomi Group team members, the deal will expand the UPS Healthcare network in Europe and Latin America by adding temperature-controlled facilities in 14 countries. The purchase will improve global healthcare logistics capabilities from beginning to end and increase scope and proficiency in Europe and Latin America.

Key Market Players

• Almac Group
• DHL
• Parexel
• Thermo Fisher Scientific (Patheon)
• Marken
• Piramal Pharma Solutions
• UDG Healthcare
• Catalent, Inc.
• FedEx
• Movianto
• Packaging Coordinators Inc.

Market Segmentation

By Service

• Logistics & Distribution
• Storage & Retention
• Packaging, Labeling, and Blinding
• Manufacturing
• Comparator Sourcing
• Others

By Phase

• Phase I
• Phase II
• Phase III
• Phase IV

By End-user

• Pharmaceuticals
• Biologicals
• Medical Device

By Therapeutic Area

• Oncology
• Cardiovascular Diseases
• Respiratory Diseases
• CNS and Mental Disorders
• Others

By Geography

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa